1. Home
  2. PAR vs NVCR Comparison

PAR vs NVCR Comparison

Compare PAR & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$14.12

Market Cap

640.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$18.01

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
NVCR
Founded
1968
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Medical/Dental Instruments
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
640.6M
1.2B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
PAR
NVCR
Price
$14.12
$18.01
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$33.20
$28.08
AVG Volume (30 Days)
1.2M
1.8M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$455,547,000.00
$655,353,000.00
Revenue This Year
$9.82
$7.72
Revenue Next Year
$11.27
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
30.16
8.28
52 Week Low
$11.59
$9.82
52 Week High
$72.15
$20.05

Technical Indicators

Market Signals
Indicator
PAR
NVCR
Relative Strength Index (RSI) 48.10 66.39
Support Level $12.32 $12.66
Resistance Level $15.10 $18.92
Average True Range (ATR) 0.99 0.93
MACD 0.03 -0.05
Stochastic Oscillator 29.74 72.16

Price Performance

Historical Comparison
PAR
NVCR

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: